A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial.

Subjects

Subjects :

Drug Combinations
Gene Expression
Interleukin-2 administration & dosage
Interleukin-2 genetics
Melanoma immunology
Melanoma pathology
Neoplasm Metastasis
Plasmids
Superantigens administration & dosage
Superantigens genetics
Superantigens therapeutic use
Clinical Protocols
Clinical Trials, Phase I as Topic methods
Genetic Therapy
Interleukin-2 therapeutic use
Melanoma therapy
Vaccines, DNA therapeutic use

Details

Language :

English

ISSN :

1043-0342

Volume :

11

Issue :

9

Database :

MEDLINE

Journal :

Human gene therapy

Publication Type :

Academic Journal

Accession number :

10890744

Full Text :

https://doi.org/10.1089/10430340050032447